Role of high mobility group (HMG) chromatin proteins in DNA repair

DNA Repair

Volumn 4, Issue 8, 2005, Pages 926-938

  Reeves, Raymond ^a   Adair, Jennifer E ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Base excision repair; Chromatin dynamics; HMGA; HMGB; HMGN; Neucleotide excision repair

Indexed keywords

CISPLATIN; HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP B PROTEIN; HIGH MOBILITY GROUP N PROTEIN; MERCAPTOPURINE; NUCLEOSIDE ANALOG; PROTEIN P53;

APOPTOSIS; CANCER GENETICS; CHROMATIN; CHROMATIN STRUCTURE; CHROMOSOMAL INSTABILITY; DNA RECOMBINATION; DNA REPAIR; EUKARYOTIC CELL; EXCISION REPAIR; GENE MUTATION; HUMAN; MAMMAL CELL; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN FUNCTION; SHORT SURVEY; ULTRAVIOLET RADIATION; YEAST CELL;

EUKARYOTA; MAMMALIA;

EID: 21844465656     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2005.04.010     Document Type: Review

References (148)

1. E.W. Johns The HMG Chromosomal Proteins 1982 Academic Press New York
2. R. Grosschedl, K. Giese, and J. Pagel HMG domain proteins: architectural elements in the assembly of nucleoprotein structures Trends Genet. 10 1994 94 100
3. M. Bustin, and R. Reeves High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function Prog. Nucleic Acid. Res. Mol. Biol. 54 1996 35 100
4. M.E. Bianchi, and M. Beltrame Upwardly mobile proteins. Workshop: the role of HMG proteins in chromatin structure, gene expression and neoplasia EMBO Rep. 1 2000 109 114
5. M. Bustin Regulation of DNA-dependent activities by the functional motifs of the high- mobility-group chromosomal proteins Mol. Cell Biol. 19 1999 5237 5246
6. Y.V. Postnikov, and M. Bustin Analysis of HMG-14/-17-containing chromatin Meth. Mol. Biol. 119 1999 303 310
7. R. Reeves Structure and function of the HMGI(Y) family of architectural transcription factors Environ. Health Perspect. 108 2000 803 809
8. R. Reeves Molecular biology of HMGA proteins: hubs of nuclear function Gene 277 2001 63 81
9. J.O. Thomas HMG1 and 2: architectural DNA-binding proteins Biochem. Soc. Trans. 29 2001 395 401
10. R. Reeves, and L. Beckerbauer HMGI/Y proteins: flexible regulators of transcription and chromatin structure Biochim. Biophys. Acta 1519 2001 13 29
11. J.O. Thomas, and A.A. Travers HMG1 and 2, and related 'architectural' DNA-binding proteins Trends Biochem Sci. 26 2001 167 174
12. M. Bustin Chromatin unfolding and activation by HMGN(*) chromosomal proteins Trends Biochem Sci. 26 2001 431 437
13. A. Agresti, and M.E. Bianchi HMGB proteins and gene expression Curr. Opin. Genet. Dev. 13 2003 170 178
14. R. Reeves, and L.M. Beckerbauer HMGA proteins as therapeutic drug targets Prog. Cell Cycle Res. 5 2003 279 286
15. R. Reeves, and D.D. Edberg J. Zlatanova S. Leuba Chromatin Structure and Dynamics: State of the Art 2004 Elsevier B.V. New York N.Y 155 180
16. S. Muller The double life of HMGB1 chromatin protein: architectural factor extracellular signal EMBO J. 20 2001 4337 4340
17. B. Degryse, and M. De Virgilio The nuclear protein HMGB1, a new kind of chemokine? FEBS Lett. 553 2003 11 17
18. J.C. Huang, D.B. Zamble, R.T. Reardon, S.J. Lippard, and A. Sankar HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease Proc. Natl. Acad. Sci. U.S.A. 91 1994 10394 10398
19. Y. Mikata, Q. He, and S.J. Lippard Laser-induced photo-cross-linking of cisplatin-modified DNA to HMG-domain proteins Biochemistry 40 2001 7533 7541
20. E.Y. Krynetski, N.F. Krynetskaia, M.E. Bianchi, and W.D. Evans A nuclear protein complex containing high mobility group proteins B1 and B2, heat shock cognate protein 70, ERp60, and the glyceraldehyde-3-phosphate dehydrogenase is involved in the cytotoxic response to DNA modified by incorporation of anticancer nucleoside analogues Cancer Res. 63 2003 100 106
21. Adair, J.E., Kwon, J.-H., Smerdon, M.J., Reeves, R., Inhibition of DNA repair by high mobility group protein HMGA1, submitted for publication.
22. Y. Birger Chromosomal protein HMGN1 enhances the rate of DNA repair in chromatin EMBO J. 22 2003 1665 1675
23. M. Bustin Revised nomenclature for high mobility group (HMG) chromosomal proteins Trends Biochem. Sci. 26 2001 152 153
24. R. Reeves, and M.S. Nissen The A T-DNA-binding domain of mammalian high mobility group I chromosomal proteins: A novel peptide motif for recognizing DNA structure J. Biol. Chem. 265 1990 8573 8582
25. H. Weir Structure of the HMG box motif in the B domain of HMG 1 EMBO J. 12 1993 1311 1319
26. C.M. Read, P.D. Cary, C. Crane-Robinson, P.C. Driscoll, and D.G. Norman Solution structure of a DNA-binding domain from HMG 1 Nucleic Acids Res. 21 1993 3427 3436
27. D.A. Hill, and R. Reeves Competition between HMG-I(Y) HMG-1 and histone H1 on four- way junction DNA Nucleic Acids. Res. 25 1997 3523 3531
28. D. Subramanian, and J.D. Griffith Interactions between p53, hMSH2-hMSH6 and HMG I(Y) on Holliday junctions and bulged bases Nucleic Acids Res. 30 2002 2427 2434
29. S.L. Bruhn, P.M. Pil, J.M. Essigmann, D.E. Housman, and S.J. Lippard Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin Proc. Natl. Acad. Sci. U.S.A. 89 1992 2307 2311
30. P.M. Pil, and S.J. Lippard Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin Science 256 1992 234 237
31. D.A. Hill, M.L. Pedulla, and R. Reeves Directional binding of HMG-I(Y) on four-way junction DNA and the molecular basis for competitive binding with HMG-1 and histone H1 Nucleic Acids Res. 27 1999 2135 2144
32. K.L. West M. Bustin J. Zlatanova S. Leuba Chromatin Structure and Dynamics: State-of-the-Art 2004 Elsevier B.V New York, N.Y. 135 154
33. R. Hock, U. Scheer, and M. Bustin Chromosomeal proteins HMG-14 and HMG-17 are released from mitotic chromosomes and imported into the nucleus by active transport J. Cell Biol. 143 1998 1427 1436
34. M.P. Crippa, P.J. Alfonso, and M. Bustin Nucleosome core binding region of chromosomal protein HMG-17 acts as an independent functional domain J. Mol. Biol. 228 1992 442 449
35. L. Trieschmann, Y.V. Postnikov, A. Rickers, and M. Bustin Modular structure of chromosomal proteins HMG-14 and HMG-17: definition of a transcriptional enhancement domain distinct from the nucleosomal binding domain Mol. Cell Biol. 15 1995 6663 6669
36. H.F. Ding, M. Bustin, and U. Hansen Alleviation of histone H1-mediated transcriptional repression and chromatin compaction by the acidic activation region in chromosomal protein HMG-14 Mol. Cell Biol. 17 1997 5843 5855
37. R. Reeves, and M.S. Nissen Interaction of high mobility group-I(Y) non-histone proteins with nucleosome core particles J. Biol. Chem. 268 1993 21137 21146
38. R. Reeves, and A.P. Wolffe Substrate structure influences binding of the non-histone protein HMG-I(Y) to free and nucleosomal DNA Biochemistry 35 1996 5063 5074
39. E.N. Hughes, B.N. Engelsberg, and P.C. Billings Purification of nuclear proteins that bind to cisplatin-damaged DNA. Identity with high mobility group proteins 1 and 2. J. Biol. Chem. 267 1992 13520 13527
40. G. Chu Cellular responses to cisplatin J. Biol. Chem. 269 1994 787 790
41. K. Wozniak, and J. Blasiak Recognition and repair of DNA-cisplatin adducts Acta Biochim. Pol. 49 2002 583 596
42. P.M. Pil, C.S. Chow, and S.J. Lippard High-mobility-group 1 protein mediates DNA bending as determined by ring closures Proc. Natl. Acad. Sci. U.S.A. 90 1993 9465 9469
43. C.S. Chow, J.P. Whitehead, and S.J. Lippard HMG domain proteins induce sharp bends in cisplatin-modified DNA Biochemistry 33 1994 15124 15130
44. C.S. Chow, C.M. Barnes, and S.J. Lippard A single domain in the high-mobility group 1 protein binds DNAs as small as 20 base pairs containing the major cisplatin adduct Biochemistry 34 1995
45. P.M. Takahara, A.C. Rosenzweig, C.A. Frederick, and S.J. Lippard Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin [see comments] Nature 377 1995 649 652
46. U.-M. Ohndorf, M.A. Rould, Q. He, C.O. Pabo, and S.J. Lippard Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins Nature 399 1999 708 712
47. D.B. Zamble, D. Mu, J.T. Reardon, A. Sancar, and S.J. Lippard Repair of cisplatin-DNA adducts by the mammalian excision nuclease Biochemistry 35 1996 10004 10013
48. E.E. Trimmer, and J.M. Essigmann Human testis-determining factor SRY binds to the major DNA adducts of cisplatin and a putative target sequence with comparable affinities Biochemistry 37 1998 352 362
49. E.E. Trimmer, and J.M. Essigmann Cisplatin Essays Biochem. 34 1999 191 211
50. P. Jordan, and M. Carmo-Fonseca Molecular mechanisms involved in cisplatin cytotoxicity Cell Mol. Life Sci. 57 2000 1229 1235
51. H. Arioka Enhancement of cisplatin sensitivity in high mobility group 2 cDNA- transfected human lung cancer cells Jpn. J. Cancer Res. 90 1999 108 115
52. S.M. Patrick, and J.J. Turchi Human replication protein A preferentially binds cisplatin- damaged duplex DNA in vitro Biochemistry 37 1998 8808 8815
53. Z. He, L.A. Henricksen, M.S. Wold, and C.J. Ingles RPA involvement in the damage-recognition and incision steps of nucleotide excision repair Nature 374 1995 566 569
54. R.D. Wood DNA repair in eukaryotes Annu. Rev. Biochem. 65 1996 135 167
55. J.H. Hoeijmakers Genomic maintenance mechanisms for preventing cancer Nature 411 2001 366 374
56. E.A. Pasheva, I.G. Pashev, and A. Favre Preferential binding of high mobility group 1 protein to UV-damaged DNA Role of the COOH-terminal domain J. Biol. Chem. 273 1998 24730 24736
57. H.J. Park Crystal structure of a DNA decamer containing a cis-syn thymine dimer. Proc. Natl. Acad. Sci., U.S.A. 99 2002 15965 95970
58. R. Holliday A mechanism for gene conversion in fungi Genet. Res. 5 1964 282 304
59. G.S. Briggs, A.A. Mahdi, G.R. Weller, Q. Wen, and R.G. Lloyd Interplay between DNA replication, recombination and repair based on the structure of RecG helicase Philos. Trans. R. Soc. Lond. B Biol. Sci. 359 2004 49 59
60. W.D. Heyer Recombination: Holliday junction resolution and crossover formation Curr. Biol. 20 14 2004 R56 R58
61. W.D. Heyer, K.T. Ehmsen, and J.A. Solinger Holliday junctions in the eukaryotic nucleus: resolution in sight? Trends Biochem. Sci. 28 2003 548 557
62. P. McGlynn, and R.G. Lloyd Genome stability and the processing of damaged replication forks by RecG Trends Genet. 18 2002 413 419
63. S.C. West The processing of recombination intermediates: mechanistic insights from studies of bacterial proteins Cell 76 1994 9 15
64. K. Giese, J. Cox, and R. Grosschedl The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures Cell 69 1992 185 195
65. C.M. Read, P.D. Cary, N.S. Preston, M. Lnenicek-Allen, and C. Crane-Robinson The DNA sequence specificity of HMG boxes lies in the minor wing of the structure EMBO J. 13 1994 5639 5646
66. A. Pontiggia Sex-reversing mutations affect the architecture of SRY-DNA complexes EMBO J. 13 1994 6115 6124
67. D.C. Van Gent, K. Hiom, T.T. Paull, and M. Gellert Stimulation of V(D)J cleavage by high mobility group proteins EMBO J. 16 1997 2665 2670
68. D.J. Sawchuk V(D)J recombination: modulation of RAG1 and RAG2 cleavage activity on 12/23 substrates by whole cell extract and DNA-bending proteins J. Exp. Med. 185 1997 2025
69. V. Aidinis The RAG1 homeodomain recruits HMG1 and HMG2 to facilitate recombination signal sequence binding and to enhance the intrinsic DNA-bending activity of RAG 1-RAG2 Mol. Cell. Biol. 19 1999 6532 6542
70. P.C. Swanson Fine Structure and Activity of Discrete RAG-HMG Complexes on V(D)J Recombination Signals Mol. Cell Biol. 2002 1340 1351
71. S.D. Fugmann, A.I. Lee, P.E. Shockett, I.J. Villey, and D.G. Schatz The RAG proteins and V(D)J recombination: complexes, ends and transposition Annu. Rev. Immunol. 18 2000 495 527
72. M. Gellert V(D)J recombination: RAG proteins, repair factors, and regulation Ann. Rev. Biochem. 71 2002 101 132
73. J. Mansilla-Soto, and P. Cortes VDJ recombination: artemis and its in vivo role in hairpin opening J. Exp. Med. 197 2003 543 547
74. S. Tonegawa Somatic generation of antibody diversity Nature 302 1983 575 581
75. C.H. Bassing, W. Swat, and F.W. Alt The mechanism and regulation of chromosomal V(D)J recombination Cell 109 2002 S45 S55
76. K. Hiom, and M. Gellert A stable RAG1-RAG2-DNA complex that is active in V(D)J cleavage Cell 88 1997 65 72
77. K. Hiom, and M. Gellert Assembly of a 12/23 paired signal complex: a critical control point in V(D)J recombination Mol. Cell 1 1998
78. T. Ueda, H. Shirakawa, and M. Yoshida Involvement of HMGB1 and HMGB2 proteins in exogenous DNA integration reaction into the genome of HeLa S3 cells Biochim. Biophys. Acta 1593 2002 77 84
79. L.J. Hofseth, S.P. Hussain, and C.C. Harris p53: 25 years after its discovery Trends Pharmacol. Sci. 25 2004 177 181
80. J.E. Sutcliffe, and A. Brehm Of flies and men; p53, a tumour suppressor FEBS Lett. 567 2004 86 91
81. P. Fei, and W.S. El Deiry P53 and radiation responses Oncogene 22 2003 5774 5783
82. S. Adimoolam, and J.M. Ford p53 and regulation of DNA damage recognition during nucleotide excision repair DNA Rep. (Amst) 2 2003 947 954
83. P.C. Hanawalt, J.M. Ford, and D.R. Lloyd Functional characterization of global genomic DNA repair and its implications for cancer Mutat. Res. 544 2003 107 114
84. C.P. Rubbi, and J. Milner p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage EMBO J. 22 2003 975 986
85. A. Sancar, L.A. Lindsey-Boltz, K. Unsal-Kaccmaz, and S. Linn Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints Annu. Rev. Biochem. 73 2004 39 85
86. B. Vogelstein, and K.W. Kinzler p53 function and disfunction Cell 70 1992 523 526
87. N. Motoyama, and K. Naka DNA damage tumor suppressor genes and genomic instability Curr. Opin. Genet. Dev. 14 2004 11 16
88. L. Jayaraman High mobility group protein-1 (HMG-1) is a unique activator of p53 Genes Dev. 12 1998 462 472
89. T. Imamura Interaction with p53 enhances binding of cisplatin-modified DNA by high mobility group 1 protein J. Biol. Chem. 276 2001 7534 7540
90. K.M. McKinney, and C. Prives Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein Mol. Cell Biol. 22 2002 6797 6808
91. K. McKinney, R. Reeves, M. Bustin, and C. Prives Molecular insights into the unique stimulation of p53 by HMG-1. Abstract: Workshop: The role of HMG proteins in chromatin structure, gene expression and neoplasia Natl. Inst. Health, Bethesda MD 2000
92. Y. Postnikov, L. Trieschmann, A. Rickers, and M. Bustin Homodimers of chromosomal proteins HMG-14 and HMG-17 in nucleosome cores J. Mol. Biol. 252 1995 423 432
93. L.H. Thompson, J.S. Rubin, J.E. Cleaver, G.F. Whitmore, and K.W Brookman A screening method for isolating DNA repair-deficient mutants of CHO cells Som. Cell Genet. 6 1980 391 405
94. D. Busch Summary of complementation groups of UV-sensitive CHO cell mutants isolated by large-scale screening Mutagenesis 4 1989 349 354
95. E.C. Friedberg, G.C. Walker, and W. Siede DNA Repair and Mutagenesis 1995 ASM Press Washington, DC
96. V.A. Bohr, C.A. Smith, D.S. Okumoto, and P.C. Hanawalt DNA repair in an active gene: removal of pyrimidine dimers from th DHFR gene of CHO cells is much more efficient than in the genome overall Cell 40 1985 359 369
97. P.C. Hanawalt Revisiting the rodent repairadox Environ. Mol. Mutagen 38 2001 89 96
98. M.J. Smerdon, and F. Thoma J.A. Nickoloff M. Hoekstra DNA Damage and Repair Volume II: DNA Repair in Higher Eukaryotes 1998 Humana Press Inc. Totawa, NJ 122 199
99. M.J. Smerdon, and A. Conconi Modulation of DNA damage and DNA repair in chromatin Prog. Nucleic Acid. Res. Mol. Biol. 62 1999 227 255
100. F. Thoma Light and dark in chromatin repair: repair of UV-induced DNA lesions by photolyase and nucleotide excision repair EMBO J. 18 1999 6585 6598
101. A.M.D.M.C Gontijo, C.M. Green, and G. Almouzni Repairing DNA damage in chromatin Biochim. 85 2003 1133 1147
102. C.L. Peterson, and J. Cote Cellular machineries for chromosomal DNA repair Genes Dev. 18 2004 602 616
103. R. Reeves, D.D. Edberg, and Y. Li Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells Mol. Cell Biol. 21 2001 575 594
104. N.R. Treff, D. Puchnik, G.A. Dement, R.L. Britt, and R. Reeves High Mobility Group A1a protein regulates Ras/ERK signaling in MCF-7 human breast cancer cells Oncogene 23 2003 777 785
105. N. Treff, R. Reeves, 2003. Unpublished data.
106. G. Baldassarre Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma Mol. Cell Biol. 23 2003 2225 2238
107. L. Borrmann, B. Seebeck, P. Rogalla, and J. Bullerdiek Human HMGA2 promoter is coregulated by a polymorphic dinucleotide (TC)-repeat Oncogene 22 2003 756 760
108. J.M. Gale, and M.J. Smerdon Photofootprint of nucleosome core DNA in intact chromatin having different structural states J. Mol. Biol. 204 1988 949 958
109. B. Vogelstein, and K.W. Kinzler The multistep nature of cancer Trends Genet. 9 1993 138 141
110. K.W. Kinzler, and B. Vogelstein Lessons from hereditary colorectal cancer Cell 87 1996 159 170
111. J.P.A. Baak Genomics and proteomics in cancer Eur. J. Cancer 39 2003 1199 1215
112. M.A. Matzke, M.F. Mette, T. Kanno, and A.J. Matzke Does the intrinsic instability of aneuploid genomes have a causal role in cancer? Trends Genet. 19 2003 253 256
113. M. Fenech Chromosomal biomarkers of genomic instability relevant to cancer Drug Discov. Today 7 2002 1128 1137
114. S. Rockwell, J. Yuan, S. Peretz, and P.M. Glazer Genomic instability in cancer Novartis. Found. Symp. 240 2001 133 142
115. A.R. Venkitaraman Chromosome instability and cancer predisposition: insights form studies on the breast cancer susceptibility gene BRCA2. Cold Spring Har. Symp. Quant. Biol. 65 2000 567 5772
116. L.A. Loeb, K.R. Loeb, and J.P. Anderson Multiple mutations and cancer Proc. Natl. Acad. Sci. U.S.A. 100 2003 776 781
117. J.F. Davidson, H.H. Guo, and L.A. Loeb Endogenous mutagenesis and cancer Mutat. Res. 509 2002 17 21
118. L.A. Loeb A mutator phenotype in cancer Cancer Res. 61 2001 3230 3239
119. K.R. Loeb, and L.A. Loeb Significance of multiple mutations in cancer Carcinogenesis 21 2000 379 385
120. L.A. Loeb Cancer cells exhibit a mutator phenotype Adv. Cancer Res. 72 1998 25 56
121. P. Duesberg, C. Rausch, D. Rasnick, and R. Hehlmann Genetic instability of cancer cells is proportional to their degree of aneuploidy Proc. Natl. Acad. Sci. U.S.A 95 1998 13692 13697
122. I. Tomlinson, and W. Bodmer Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog Nat. Med. 5 1999 11 12
123. T.L. Wang Prevalence of somatic alterations in the colorectal cancer cell genome Proc. Natl. Acad. Sci. U.S.A 99 2002 3076 3080
124. L.A. Loeb, C.F. Springgate, and N. Battula Errors in DNA replication as a basis of malignant changes Cancer Res. 34 1974 2311 2321
125. L.A. Loeb Many mutations in cancers Cancer Surv. 28 1996 329 342
126. L.P. Bignold The mutator phenotype theory of carcinogenesis and the complex histopathology of tumours: support for the theory from the independent occurrence of nuclear abnormality, loss of specialisation and invasiveness among occasional neoplastic lesions Cell Mol. Life Sci. 60 2003 883 891
127. L.P. Bignold The mutator phenotype theory can explain the complex morphology and behaviour of cancers Cell Mol. Life Sci. 59 2002 950 958
128. L.P. Bignold Initiation of genetic instability and tumour formation: a review and hypothesis of a nongenotoxic mechanism Cell Mol. Life Sci. 60 2003 1107 1117
129. G. Tallini, and P. Dal Cin Hmgi(Y) and HMGI-C dysregulation: a common occurrence in human tumors Adv. Anat. Pathol. 6 1999 237 246
130. S. Galande Chromatin (dis)organization and cancer: BUR-binding proteins as biomarkers for cancer Curr. Cancer Drug Targets 2 2002 157 190
131. K.E. Van Holde Chromatin 1989 Springer-Verlag New York
132. A.P. Wolffe Chromatin Structure and Function 1998 Academic Press, Harcourt Brace & Co. Publishers New York
133. M.J. Smerdon, and A. Conconi Modulation of DNA damage and DNA repair in chromatin Prog. Nucleic Acid. Res. Mol. Biol. 62 1999 227 255
134. T.K. Meyvis, S.C. De Smedt, P. Van Oostveldt, and J. Demeester Fluorescence recovery after photobleaching: a versatile tool for mobility and interaction measurements in pharmaceutical research Pharm. Res. 16 1999 1153 1162
135. J. Lippincott-Schwartz, and G.H. Patterson Development and use of fluorescent protein markers in living cells Science 300 2003 87 91
136. T. Haraguchi Live cell imaging: approaches for studying protein dynamics in living cells Cell Struct. Funct. 27 2002 333 334
137. R.D. Phair Global nature of dynamic protein-chromatin interactions in vivo: three- dimensional genome scanning and dynamic interaction networks of chromatin proteins Mol. Cell Biol. 24 2004 6393 6402
138. J.E. Disney, K.R. Johnson, N.S. Magnuson, S.R. Sylvester, and R. Reeves High-mobility group protein HMG-I localizes to G/Q- and C-bands of human and mouse chromosomes J. Cell Biol. 109 1989 1975 1982
139. M. Harrer, H. Luhrs, M. Bustin, U. Scheer, and R. Hock Dynamic interaction of HMGA1a proteins with chromatin J. Cell Sci. 117 2004 3459 3471
140. F. Catez Network of dynamic interactions between histone H1 and high-mobility- group proteins in chromatin Mol. Cell Biol. 24 2004 4321 4328
141. T. Boulikas DNA lesion-recognizing proteins and the p53 connection Anticancer Res. 16 1996 225 242
142. H. Nilsen, T. Lindahl, and A. Verreault DNA base excision repair of uracil residues in reconstituted nucleosome core particles EMBO J. 21 2002 5943 5952
143. B.C. Beard, S.H. Wilson, and M.J. Smerdon Suppressed catalytic activity of base excision repair enzymes on rotationally positioned uracil in nucleosomes Proc. Natl. Acad. Sci. U.S.A 100 2003 7465 7470
144. A. Hara, A. Mo, and A. Sancar DNA damage in the nucleosome core is refractory to repair by human excision nuclease Mol. Cell. Biol. 20 2000 9173 9181
145. P.J. Horn, and C.L. Peterson Molecular Biology: chromatin higher order folding- wrapping up transcription Science 297 2002 1824 1827
146. P.B. Becker Nucleosome sliding: facts and fiction EMBO J. 21 2002 4749 4753
147. S.D. Cline, and P.C. Hanawalt Who's on first in the cellular response to DNA damage? Naure Reviews Mol. Cell. Biol. 4 2003 361 372
148. L. Beckerbauer, J.J. Tepe, J. Cullison, R. Reeves, and R.M. Williams FR900482 class of antitumor drugs cross-links oncoprotein HMG I/Y to DNA in vivo Chem. Biol. 7 2000 805 812